Related Experiment Video
Updated: Sep 2, 2025

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
583
Survival Benefit of Neoadjuvant Therapy for Extrahepatic Cholangiocarcinoma: Real or Artifact?
1Division of Surgical Oncology, Department of Surgery, Brody School of Medicine at East, Carolina University, 600 Moye Boulevard, Suite 4S-24, Greenville, NC, 27834, USA. snyderre19@ecu.edu.
Annals of Surgical Oncology
|August 10, 2022
Abstract
No abstract available in PubMed .

